We describe a rare case of transient thyrotoxicosis secondary to painless thyroiditis accompanied by panhypopituitarism caused by ruptured Rathke's cleft cyst. A 32-year-old man presented with vomiting and diarrhea. Laboratory data showed that he had transient hypercalcemia, primary thyrotoxicosis due to painless thyroiditis and panhypopituitarism. The sellar magnetic resonance imaging showed cystic macroadenoma. He underwent surgical exploration. Histological examination showed a ruptured Rathke's cleft cyst. Our case suggests that, although rare, it is important to recognize the possibility of coexistence of hypopituitarism in patients with primary thyrotoxicosis.
Introduction
Rathke's cleft cysts (RCCs) are usually asymptomatic epithelial lesions of sellar and suprasellar regions, which are found in about 20% of autopsies (1) . RCCs infrequently enlarge and can cause compression of sellar and suprasellar structures, resulting in symptoms of mass effects and endocrine disturbances (2) . Rarely, RCC rupture may occur, and inflammatory hypophysitis due to ruptured RCC may cause hypopituitarism (3, 4) .
Painless thyroiditis develops in patients with underlying autoimmune thyroid disease (5) . Thyrotoxicosis due to painless thyroiditis is caused by a breakdown of thyroid cells, and this process is usually followed by recovery of thyroid function. Several cases of coexistence of hypopituitarism and primary thyrotoxicosis have been reported (6) (7) (8) . However, thyrotoxicosis in the setting of a ruptured RCC has not been described in the literature. In clinical practice, although a combination of primary thyrotoxicosis and hypopituitarism is rare, it is very important to recognize these conditions, as thyroid hormone excess may mask a deficient status of thyroid stimulating hormone (TSH) and may aggravate a deficient cortisol status. Here, we describe a case of transient thyrotoxicosis due to painless thyroiditis and hypercalcemia accompanied by panhypopituitarism caused by a ruptured RCC.
Case Report
A 32-year-old man presented to the hospital with vomiting and diarrhea. He did not smoke or drink, and had no family history of endocrine or autoimmune disorders. Upon admission, he was 173 cm tall and weighed 58 kg. He had a body temperature of 36.1 , a heart rate of 80 beats/min, and a blood pressure of 130/80 mmHg. He was alert. No pigmentation was observed in his skin and mucosa. Ophthalmological examinations including visual acuity and visual fields showed no abnormalities. He had no goiter, tenderness or thyroid bruit. He had decreased libido and erectile dysfunction. Although he had no axillary hair, the size of his testes was normal for his age. Neurologic examinations revealed no abnormalities. Laboratory findings were as follows: white blood cells 5,900/mm 3 (reference range: 4,300-10,800), blood urea nitrogen 18.4 mg/dL (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) , creatinine 0.7 mg/dL (0.5-1.3), sodium 135 mEq/L (136-146), potas- -20) . The urine volume was 1,800 mL/day. Thyroid hormone levels were increased, and the thyroid stimulating hormone (TSH) level was undetectable (Table 1). Antithyroglobulin antibodies were positive. The thyroidal pertechnetate scan showed even parenchymal uptake in both thyroid lobes (Fig. 1A) . Thyroidal radioactive iodine uptake at 6 hours and 24 hours was 3 and 2 percent, respectively. Thus, he was diagnosed as having painless thyroiditis with thyrotoxicosis. Endocrine examination showed inappropriate gonodotropic hormone levels with a low testosterone level, low insulin-like growth factor (IGF) I level for his age-adjusted normal range, adrenocorticotropic hormone (ACTH) and cortisol levels in the lower limit of the normal range, suggesting hypopituitarism. Sellar magnetic resonance imaging (MRI) showed an intra-and supra-sellar lesion measuring 1.8×1.8×1.4 cm without displacement of the optic chiasm (Fig. 1B) . The mass had isosignal intensity on T1-weighted images. Gadolinium-enhanced T1-weighted images showed peripheral contrast enhancement sparing in the central cystic parts. The neuroradiological diagnosis was cystic macroadenoma. To reduce thyrotoxic symptoms and to manage hypercalcemia, he was treated with intravenous fluids and propranolol. In addition, as thyroid hormone excess can increase the turnover of cortisol in the setting of inappropriately low cortisol status, he was treated with intravenous hydrocortisone. We decided to operate after improvement of the thyrotoxciosis. After improvement of symptoms, he was discharged on hydrocortisone 20 mg/day and propranolol 120 mg/day. After 1 month, thyroid hormones decreased fur- Table 1 ). The serum total calcium and ionized calcium levels decreased to 10.3 mg/dL and 5.4 mg/dL, respectively. However, the patient was lost to follow-up thereafter. After 6 months the patient revisited our hospital with a complaint of general fatigue. At that time, thyrotoxicosis and hypercalcemia were resolved. The urine volume was 2,200 mL/day. Endocrinological re-assessment showed either no or little response to the respective anterior pituitary hormonal stimuli: ACTH and growth hormone to insulin induced hypoglycemia, TSH and prolactin to TSH-releasing hormone (TRH), and luteinizing hormone (LH) and follicle stimulating hormone (FSH) to gonadotropin-releasing hormone (GnRH), which showed advanced pituitary hormonal dysfunction (Table 1). He underwent a surgical exploration via transsphenoidal approach. Intraoperatively, adhesions between the cystic wall and the dura were observed, suggesting inflammatory changes. The yellowish-green fluid was extruded from the cystic cavity. Bacteriological examination revealed negative results. Histological examination of the specimen revealed a cuboidal epithelial lining on the surface of the cyst wall, infiltration by chronic inflammatory cells, fragments of epithelial cells, and collagenous fibrous tissue, all consistent with a ruptured Rathke's cleft cyst (Fig. 2) . No giant cells were observed. After surgery, he was doing well with hormone replacement for panhypopituitarism.
Discussion
RCCs are believed to be a cystic remnant resulting from inadequate obliteration of Rathke's pouch, situated between the anterior and posterior pituitary lobes (1). RCCs are usually asymptomatic. Symptomatic RCCs are uncommon and usually present with headaches, visual impairment, and endocrine disturbances. Several studies reported that the common hormonal changes found in symptomatic RCCs were panhypopituitarism, hyperprolactinemia, and gonadotropin deficiency (1, 9, 10) . MRI findings of RCCs are known to depend mostly on the underlying pathology and the bio-chemical profiles of cystic contents. In many cases, with peripheral rim enhancement, RCCs show low signal intensity on T1-weighted images like the density of cerebrospinal fluid (1) . However, in the present case, the RCC revealed isosignal intensity on T1-weighted images. Some studies reported that RCCs might appear isointense to hyperintense on T1-weighted images in the presence of a high mucopolysaccharide content or hemorrhage (1, 11). Saeki et al (12) reported that RCCs with iso-to high intensity on T1-weighted imaging might cause symptoms in a small size compared with RCCs with low intensity.
Rarely, these patients may present with ruptured RCCs, as in the present case. The cause of RCC rupture is not known. In asymptomatic RCCs, an inflammatory reaction is not found. In contrast, leakage of the cyst contents in ruptured RCCs induces inflammation and can cause hypopituitarism with its mass effects (3, 4) . Histological examination of ruptured RCCs reveals several types of hypophysitis such as lymphocytic, granulomatous, and xanthogranulomatous hypophysitis, according to the predominant cell type (4). Biochemical composition of the cystic contents may contribute to characteristics of the inflammatory reaction (4) . In the present case, with endocrine manifestations of panhypopituitarism, histological findings showed predominantly lymphocytic infiltration as well as a fragment of epithelial cells, which are characteristics of ruptured RCC. However, in the present case, we could not precisely explain when the rupture occurred. Nishioka et al (13) reported that RCCs with iso-and high intensity on T1-weighted images, which contained mucus within the cyst, might be associated with chronic inflammation resulting in irreversible endocrine dysfunction. Nishikawa et al (3) reported a case of a ruptured RCC which exhibited a shrinkage of the cyst on a follow-up neuroimaging study with the development of hypopituitarism. Thus, in the present case, it might be suggested, that the rupture might have occurred during the follow-up period although he exhibited partial pituitary dysfunction at the initial visit. However, as a follow-up MRI was not performed before operation, the possibility that the rupture of RCC existed at the initial visit might also be considered.
Asymptomatic patients with normal pituitary function in RCCs can be treated conservatively. The surgery in RCCs is indicated in symptomatic patients with visual disturbance and pituitary insufficiency. However, the endocrine outcomes following surgery remain poor, as the recovery of pituitary function is not common. Among the hormonal abnormalities, the most favorable outcome is observed in hyperprolactinemia (1, 14) . Reversals from panhypopituitarism are not common findings (1, 13, 14) . el-Mahdy and Powell (1) reported that in patients with symptomatic RCCs, about 62% of patients with preoperative hyperprolactinemia achieved normal or nearly normal levels postoperatively, whereas restoration of normal gonadotrophin concentrations was achieved in about 20% of patients with low preoperative gonadotrophin levels, and restoration of normal serum cortisol concentrations was achieved in about 15% of patients with preoperative panhypopituitarism postoperatively.
From the clinical point of view, it is important to recognize the possibility of the coexistence of two opposite conditions in endocrine disorders. The present case showed development of transient thyrotoxicosis secondary to painless thyroiditis in the setting of hypopituitarism. In our case, during the initial visit, documentation of TSH deficiency was difficult as the patient was thyrotoxic, but the deficiency was evident when he became hypothyroid. Also, the TSH response to TRH stimulation was blunted. The pathogenic trigger for spontaneous painless thyroiditis is unknown, but there are suggestions that it is due to immunologic change related to autoimmune thyroiditis. Endogeneous glucocorticoids may normally control inflammation and autoimmune reactions. An imbalance of the immune-hypothalamopituitary-adrenal circuit may be a component in the development of autoimmune disease (15) . In an animal study, the obese strain (OS) chickens with the reduced concentrations of active plasma corticosterone and the defects in the increase of plasma corticosterone in response to antigenic stimuli showed a thyroid dysfunction mimicking human Hashimoto's thyroiditis (15) . Maruyama et al (16) reported that transient thyrotoxicosis developed after cessation of steroid therapy in a patient with autoimmune thyroiditis and rheumatoid arthritis, and plasma cortisol concentration was 6.7 μg/dL when thyrotoxicosis developed. Wada et al (17) reported the simultaneous occurrence of hyperthyroidism and ACTH deficiency due to a hypothalamic tumor. Takasu et al (18) reported that there were exacerbations of autoimmune thyroid dysfunction during the period of glucocorticoid tapering after unilateral adrenalectomy in patients with adrenal Cushing's syndrome. Also, Haraguchi et al (19) showed that painless thyroiditis developed during the replacement of glucocorticoid after unilateral adrenalectomy in patients with Cushing's syndrome. Sasaki et al (20) reported the simultaneous occurrence of painless thyroiditis and hypopituitarism following pituitary apoplexy. In the present case, the levels of ACTH and cortisol were inappropriately low under stressful conditions, although we did not document the ACTH and cortisol response to insulin tolerance test during the initial visit. Thus, the pathogenic trigger for painless thyroiditis might be related to the impairments in the immunosurveillance system of the hypothalamopituitary-adrenocortical axis associated with the development or progression of adrenal insufficiency. However, further investigation is necessary in this regard.
The current patient showed hypercalcemia at the initial visit. Although primary hyperparathyroidism and malignancy are the frequent causes of hypercalcemia (21) , thyrotoxicosis may present with hypercalcemia in about 20% of thyrotoxic patients (22) . However, hypercalcemia in thyrotoxicosis is usually mild, and serum calcium levels seldom exceed 11 mg/dL (23) . An increase in serum calcium suppresses parathyroid hormone secretion, resulting in a decrease in serum 1,25-dihydroxyvitamin D. Also, the excess thyroid hormone is associated with an increased excretion of calcium in the urine. Thus, severe hypercalcemia in thyrotoxicosis usually does not develop. However, in the present case, despite the suppressed levels of PTH and 1,25-dihydroxyvitamin D and slightly increased urinary calcium excretion, the serum calcium level was inappropriately high. Bone turnover markers such as serum alkaline phosphatase activity and osteocalcin level were increased. Although the mechanism of hypercalemia in thyrotoxic states is incompletely understood, an accelerated mobilization of calcium resulting from an increased turnover of bone may contribute to the hypercalcemia (24) . Hypercalcemia may also occur in the presence of adrenal insufficiency. Muls et al (25) showed that, in glucorcorticoid deficiency, hypercalcemia resulted from a combination of increased calcium mobilization from bone and a low renal clearance of calcium due to decreased glomerular filtration and increased tubular calcium reabsorption. Thus, urinary calcium excretion due to an excessive thyroid state and accompanied by glucorcorticoid deficiency may be impaired, resulting in exacerbation of hypercalcemia. Despite continued ACTH deficiency and no hydrocortisone replacement during follow-up loss in the present case, the patient's hypercalcemia resolved from with improvement of the thyrotoxic phase. Thus, thyrotoxicosis and volume depletion might have dominantly contributed to the hypercalcemia in this case. In summary, our case suggests that although it is rare, the coexistence of hypopituitarism should be considered in patients with thyrotoxicosis in clinical practice.
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